The
global smoking cessation and nicotine de-addiction productsmarket was
valued at USD 5.1 billion in 2012 and is expected to grow at a CAGR
of 18.7% from 2013 to 2019, to reach an estimated value of USD
16.02billion in 2019.
Smoking
cessation is a process of discontinuing smoking achieved by the use
of medication. It may also be coupled with assistance of healthcare
professionals, counselling and psychotherapy. The demand for smoking
cessation products is high and is continuously rising as it caters to
the needs of people addicted to nicotine and rising healthcare
awareness amongst the smokers. The global smoking cessation and
nicotine de-addiction products market is segmented on the basis of
product types available in the market. These include nicotine
replacement therapy (NRT) products, drug therapy and e-cigarettes.
This market is sustained by large number of people wanting to quit
smoking.
Browse
Global Smoking Cessation and Nicotine De-addiction Products Market
Report with Full TOC at
http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html
NRT
products for smoking cessation include nicotine containing gums,
patches, lozenges, sublingual tablets, inhalers and mouth sprays. The
market for NRT products is dominated by the revenue of nicotine gums,
patches and lozenges. Nicotine gums are one of the most widely used
NRT products, and the market for these was valued at USD 995.5
million in 2012. The nicotine patches and lozenges market is driven
by its ease of use and non-prescription sale. Nicotine sprays and
inhalers on the other hand are less preferred due to their high cost
and less popularity. However, increased promotional activities and
effective distribution is expected to boost their market growth in
the near future. The major players in the NRT products market include
Johnson and Johnson, GSK, Cipla and Novartis.
Smoking
cessation drug therapy market is expected to witness a decline in
revenue across the globe, by the end of the forecast period due to
patent expiration of the key revenue generating drugs Zyban
(bupropion) in 2013 and Chantix/Champix (varenicline) in 2018 (which
will impede market growth toa lower extent). The loss of patent and
marketing exclusivity will lead to a drastic reduction in revenue and
in turn provide an opportunity to generic manufacturers to launch
their own versions of these brands. The leading players in the drug
therapy market are GSK and Pfizer.
The
e-cigarettes segment is expected to witness the fastest growth, and
thus, will boost growth of the global smoking cessation and nicotine
de-addiction products market during the forecast period. E-cigarettes
have proved to be a better alternative to cigarettes whose smoke
contains various harmful gases and cause dreadful diseases such as
cancer. With the exceptional growth and popularity among the younger
population, the market has posed a challenge to other smoking
cessation products as well as to the tobacco cigarette business. The
global e-cigarettes market was worth USD 1,662.5 million in 2012.
Lorillard, NJOY and VMR products LLC are some of the major players in
the e-cigarettes market.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1849
Geographically,
North America dominates the global smoking cessation and nicotine
de-addiction products market. The North American market for smoking
cessation products was valued at USD 1,958.8 million in the year
2012. An increase in cigarette costs is expected to reduce smoking
rates significantly, especially in adolescents. According to the CDC,
a 10% rise in cigarettes cost can cut around 4% of young adults
craving cigarette consumption. The European market held the second
largest share worldwide, in 2012. WHO reports that European countries
have widely adopted bans on tobacco advertising, promotion on
national/international television and radio, billboards and outdoor
advertising, local magazines and newspapers. However, some countries
in Europe still lack in implementing measures of the WHO Framework
Convention on Tobacco Control (FCTC).
Raising
taxes to increase the cost of cigarettes can reduce tobacco use, cut
smoking rates, and ultimately save lives. Smoking prevalence has been
varying across the globe with many developing countries witnessing
rapid increase in the prevalence rate, which will create huge health
problems for the future if left unchecked. Demand for lifestyle drugs
in emerging countries is witnessing rapid growth due to factors
including growing health awareness, increase in population, and
development of public healthcare systems, among others. This is
driving people towards quitting smoking by adopting smoking cessation
products. A study in the Eastern Mediterranean Health Journal,
published in 2012, reported that nicotine containing medications are
not available in one third of the developing countries, which include
the Middle East and Africa. Moreover, accessibility of non-nicotine
containing medications such as bupropion and varenicline is also
extremely low. Increased attention and resources are needed to
address lack of smoking cessation services as well as access to
nicotine containing medications in these regions.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
The
global smoking cessation and nicotine de-addiction products market is
segmented as follows
Smoking
Cessation and Nicotine De-Addiction Products Market, by Product Type
Browse
all Article :
http://www.transparencymarketresearch.com/articles.htm
Nicotine
Replacement Therapy Products
Nicotine
Gums
Nicotine
Transdermal Patches
Nicotine
Lozenges
Nicotine
Sprays
Nicotine
Inhalers
Nicotine
Sublingual Tablets
Drug
Therapy
Zyban
(bupropion)
Chantix/Champix (varenicline)
E-cigarettes
Smoking
Cessation and Nicotine De-Addiction Products Market, by Geography
North
America
Europe
Asia-Pacific
Rest
of the World (RoW)
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Web:
http://www.transparencymarketresearch.com/
Blog:
http://www.tmrblog.com/
No comments:
Post a Comment